Stada Group
Frank Staud has held various executive positions in corporate communications and branding. Frank served as the Chief Marketing Officer at PEMA Group before joining STADA as the Executive Vice President of Corporate Communications, Branding, and Sponsoring. In the past, Frank also worked as the Executive Vice President of Corporate Communications at Actavis and as the Chefredakteur at Tiroler Tageszeitung.
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.